Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein
about
A family of insulin-like growth factor II mRNA-binding proteins represses translation in late developmentDifferential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteinsDwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient miceA novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinomaThe N-terminus of FILIA Forms an Atypical KH Domain with a Unique Extension Involved in Interaction with RNAThe RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cellsIMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expressionVICKZ proteins: a multi-talented family of regulatory RNA-binding proteinsAberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis.Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis.De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma.Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library.Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma.Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survivalHumoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.Strategies for the detection of disease genes in pancreatic cancer.Role of IGF2BP3 in trophoblast cell invasion and migrationDetection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer.IMP3 expression is associated with epithelial-mesenchymal transition in breast cancer.Expression of Hqk encoding a KH RNA binding protein is altered in human glioma.Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer.PKCα binds G3BP2 and regulates stress granule formation following cellular stressIGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer.Finding the right RNA: identification of cellular mRNA substrates for RNA-binding proteins.The KH domains of Xenopus Vg1RBP mediate RNA binding and self-associationIMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesisIMP3 signatures of fallopian tube: a risk for pelvic serous cancers.Up-regulation of Imp3 confers in vivo tumorigenicity on murine osteosarcoma cells.Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.Differential expression of IMP3 between male and female mature teratomas--immunohistochemical evidence of malignant nature.RNA-binding protein conserved in both microtubule- and microfilament-based RNA localization.RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation.Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.Autoimmune Response to IGF2 mRNA-Binding Protein 2 (IMP2/p62) in Breast Cancer.Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.Prognostic value of the IASLC/ATS/ERS classification and IMP3 expression in lung adenocarcinoma of Chinese cases
P2860
Q22008676-9C61A3EA-373C-4C27-84F4-9653B1DD8971Q24298154-6AA75F3D-5D51-4E81-BDFC-A3BFBC4AE0EFQ24548296-D1EEC351-C4AF-4CB5-B90B-364897B2297EQ24567609-B58A4427-B8A7-4590-8FF5-D6DE5BFC8140Q24676730-1F6A14EC-62CE-4320-BA7E-160009038DD9Q27676884-6E5B5DE2-5C30-4A57-81C1-6238E7EAABC0Q28238616-040F6990-D141-4CEC-8D69-CD294276735AQ28280976-349F9798-4A82-4850-97BF-02DD4B5C68FEQ28298447-84F3EA68-A669-44D5-8885-DB4DC9C847A5Q30713843-4CFF62B8-C3F5-48DE-A9AE-8EBC5D3DCB22Q31048088-C4C87380-C4F4-4C4D-9B38-C28C03CA6622Q31152796-68B17029-E5F1-4785-9A78-F0A23A97B266Q31938591-7008E030-0B72-46C2-AD4C-AD18093413E1Q32061664-546C8305-FC28-4293-9F20-2624E76C7641Q33274978-C0C512A5-6ECA-42EA-97DD-FE4492B98A5BQ33533645-6CB1B992-9DE6-4AD7-ACDE-8E36BDDAC154Q33608271-B1BB8CDB-61B9-48E9-B7DB-91C488215A16Q33692996-80FF2C15-39AA-4C06-915F-FECB64AD808FQ33694962-5583DCC0-CDF7-4A43-99EE-F126675C3D7EQ33890172-277486A4-9D94-4B80-8712-6A4F4B600941Q33898581-F08C65B6-4C43-478E-B081-258FB70C3A94Q34115156-7A26FDCD-A7CA-4916-B81B-399557054F4CQ34138916-0D2E925F-4516-4CDF-80BA-FBFC81676579Q34271052-4A694D3A-10D2-4027-9FC0-47718DF567D4Q34334410-B5A056F9-DA6F-49CA-BDCD-1FBCE395B21AQ34362046-7DF7C8EB-00AD-4D91-A919-1FA8490E98B0Q34364789-13A44FD8-808F-4034-8A1C-ABEE075805D7Q34468574-1BA0E3E4-55AC-4AAC-B2F4-821A3E5F5C43Q34504360-75239EEA-67E1-4845-9557-E27741E2A78AQ34505648-702A37EF-AD8F-4A41-B305-D343285DCC08Q35059164-A43CB62F-1429-4783-B6AE-C6BC63973F1DQ35113770-34E1A602-3F00-4F05-92FE-8B06A056F426Q35201249-A76FEA4C-6A36-4FB6-AA97-344F41288B82Q35213255-D8203FC5-ACA0-4160-82D2-36ABF09A03A9Q35583352-38A56649-E3CD-460A-9B8E-D759112B0495Q35607101-AE3D0C68-B295-4E9F-9A27-1CDBC727AECDQ35863071-EA1A970B-22A1-4A19-BA41-2F531761B30AQ35900481-DCF2EB9A-FB23-4405-8CEE-C8D2F612B282Q35916537-60342C66-979D-45CC-865E-4D071739C85DQ35993153-27E98558-DE20-43D3-B4B1-858BE3EDF955
P2860
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Cloning of a gene highly overe ...... l KH-domain containing protein
@ast
Cloning of a gene highly overe ...... l KH-domain containing protein
@en
Cloning of a gene highly overe ...... l KH-domain containing protein
@nl
type
label
Cloning of a gene highly overe ...... l KH-domain containing protein
@ast
Cloning of a gene highly overe ...... l KH-domain containing protein
@en
Cloning of a gene highly overe ...... l KH-domain containing protein
@nl
prefLabel
Cloning of a gene highly overe ...... l KH-domain containing protein
@ast
Cloning of a gene highly overe ...... l KH-domain containing protein
@en
Cloning of a gene highly overe ...... l KH-domain containing protein
@nl
P2093
P3181
P356
P1433
P1476
Cloning of a gene highly overe ...... l KH-domain containing protein
@en
P2093
C Wallrapp
F Müeller-Pillasch
F Zimmerhackl
H Hameister
P2888
P304
P3181
P356
10.1038/SJ.ONC.1201110
P407
P577
1997-06-05T00:00:00Z
P5875
P6179
1025232291